DK0785781T3 - Anvendelse af indolderivater til behandling af dermatologiske lidelser, perifer neuropatisk arthritis, allergisk eller kronisk obstruktiv lungesygdom, glaukom og okulær inflammation - Google Patents

Anvendelse af indolderivater til behandling af dermatologiske lidelser, perifer neuropatisk arthritis, allergisk eller kronisk obstruktiv lungesygdom, glaukom og okulær inflammation

Info

Publication number: DK0785781T3
Authority: DK; Denmark
Prior art keywords: glaucoma; allergic; treatment; chronic obstructive; ocular inflammation
Prior art date: 1994-10-12

Application number

DK95934662T

Other languages

English (en)

Inventor

Martin James Wythes

Kathryn Louise Monkhouse

Gillian Christine Land

Paul Gupta

Juan Lahuerta

Shirley Jones

Susan Frances Robson

Gillian Mary Ryder Samuels

Alan Brian Wilson

Original Assignee

Pfizer Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-12

Filing date

1995-10-05

Publication date

2002-03-18

1995-10-05 Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev

2002-03-18 Application granted granted Critical

2002-03-18 Publication of DK0785781T3 publication Critical patent/DK0785781T3/da

Links

208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 title abstract 2
208000010412 Glaucoma Diseases 0.000 title abstract 2
206010061218 Inflammation Diseases 0.000 title abstract 2
208000026935 allergic disease Diseases 0.000 title abstract 2
230000000172 allergic effect Effects 0.000 title abstract 2
206010003246 arthritis Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
208000035475 disorder Diseases 0.000 title abstract 2
230000004054 inflammatory process Effects 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
229940054051 antipsychotic indole derivative Drugs 0.000 title 1
150000002475 indoles Chemical class 0.000 title 1
230000002981 neuropathic effect Effects 0.000 title 1
230000002093 peripheral effect Effects 0.000 title 1
206010019233 Headaches Diseases 0.000 abstract 2
208000019695 Migraine disease Diseases 0.000 abstract 2
206010027599 migraine Diseases 0.000 abstract 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
206010016059 Facial pain Diseases 0.000 abstract 1
208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
206010043269 Tension headache Diseases 0.000 abstract 1
208000008548 Tension-Type Headache Diseases 0.000 abstract 1
208000025609 Urogenital disease Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000010643 digestive system disease Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
208000018685 gastrointestinal system disease Diseases 0.000 abstract 1
231100000869 headache Toxicity 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
208000027232 peripheral nervous system disease Diseases 0.000 abstract 1
208000033808 peripheral neuropathy Diseases 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Otolaryngology (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK95934662T 1994-10-12 1995-10-05 Anvendelse af indolderivater til behandling af dermatologiske lidelser, perifer neuropatisk arthritis, allergisk eller kronisk obstruktiv lungesygdom, glaukom og okulær inflammation DK0785781T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9420529A GB9420529D0 (en)	1994-10-12	1994-10-12	Indoles
PCT/EP1995/003965 WO1996011685A2 (en)	1994-10-12	1995-10-05	Use of indole derivatives for the treatment of various diseases

Publications (1)

Publication Number	Publication Date
DK0785781T3 true DK0785781T3 (da)	2002-03-18

Family

ID=10762708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95934662T DK0785781T3 (da)	1994-10-12	1995-10-05	Anvendelse af indolderivater til behandling af dermatologiske lidelser, perifer neuropatisk arthritis, allergisk eller kronisk obstruktiv lungesygdom, glaukom og okulær inflammation

Country Status (25)

Country	Link
US (2)	US6455567B1 (da)
EP (1)	EP0785781B1 (da)
JP (2)	JP3096306B2 (da)
KR (1)	KR970705992A (da)
CN (1)	CN1160347A (da)
AT (1)	ATE210980T1 (da)
AU (1)	AU3699795A (da)
BR (1)	BR9504375A (da)
CA (1)	CA2202484C (da)
CO (1)	CO4480025A1 (da)
CZ (1)	CZ285633B6 (da)
DE (1)	DE69524780T2 (da)
DK (1)	DK0785781T3 (da)
ES (1)	ES2167465T3 (da)
FI (1)	FI971527A7 (da)
GB (1)	GB9420529D0 (da)
HU (1)	HUT77317A (da)
IL (1)	IL115530A (da)
MX (1)	MX9702732A (da)
NO (1)	NO971606L (da)
PE (1)	PE47296A1 (da)
PL (1)	PL319868A1 (da)
PT (1)	PT785781E (da)
WO (1)	WO1996011685A2 (da)
ZA (1)	ZA958557B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9424471D0 (en) *	1994-12-03	1995-01-18	Pfizer Ltd	Treatment of emesis
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
WO2001052876A1 (en) *	2000-01-18	2001-07-26	Merck & Co., Inc.	Ophthalmic compositions for treating ocular hypertension
ES2172415B2 (es)	2000-07-28	2003-11-16	Univ Madrid Complutense	Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
KR20030046395A (ko) *	2000-07-28	2003-06-12	인스파이어 파마슈티컬스 인코퍼레이티드	인돌 유도체를 사용하여 안압을 감소시키는 방법
EP1452167A1 (de) *	2003-02-28	2004-09-01	Cognis France S.A.	Kosmetische, pharmazeutische und/oder dermatologische Zubereitungen enthaltend einen Extrakt aus Eperua falcata
US20040192754A1 (en) *	2003-03-24	2004-09-30	Shapira Nathan Andrew	Methods for treating idiopathic hyperhidrosis and associated conditions
DE10337184A1 (de) *	2003-08-13	2005-03-10	Gruenenthal Gmbh	Substituierte 3-Pyrrolidin-Indol-Derivate
RU2317805C2 (ru) *	2005-12-15	2008-02-27	Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава)	Способ лечения острых посттравматических цефалгий
US8916611B2 (en) *	2006-04-28	2014-12-23	Warsaw Orthopedic, Inc.	Pharmaceutical removal of neuronal extensions from a degenerating disc
US9789161B2 (en) *	2006-04-28	2017-10-17	Warsaw Orthopedic, Inc.	Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
US20070253960A1 (en) *	2006-04-28	2007-11-01	Josee Roy	Pharmaceutical removal of vascular extensions from a degenerating disc
CN103479624B (zh) *	2013-10-10	2015-06-17	嵊州市诺米克进出口有限公司	Racemosins A在制备治疗或预防口腔溃疡药物中的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3719924A1 (de) *	1986-12-22	1988-06-30	Bayer Ag	8-substituierte 2-aminotetraline
GB2222768B (en) *	1988-06-17	1992-01-22	Nat Res Dev	Analgesic compounds and compositions
US5559129A (en) *	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
US5578612A (en)	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5559246A (en)	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
PL170330B1 (pl) *	1990-10-15	1996-11-29	Pfizer	Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
US5545644A (en)	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5607951A (en)	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
HUT69705A (en)	1991-11-25	1995-09-28	Pfizer	Indole derivatives
US5409941A (en)	1992-02-03	1995-04-25	Pfizer Inc.	5-heteroyl indole derivatives
TW288010B (da)	1992-03-05	1996-10-11	Pfizer
GB9207396D0 (en) *	1992-04-03	1992-05-13	Merck Sharp & Dohme	Therapeutic agents
US5747501A (en)	1992-04-07	1998-05-05	Pfizer, Inc.	Indole derivatives
GB9207930D0 (en)	1992-04-10	1992-05-27	Pfizer Ltd	Indoles
NZ251047A (en)	1992-04-10	1996-09-25	Pfizer	Acylaminoindole derivatives and medicaments
GB9208161D0 (en)	1992-04-14	1992-05-27	Pfizer Ltd	Indoles
TW251284B (da)	1992-11-02	1995-07-11	Pfizer
GB9226532D0 (en) *	1992-12-21	1993-02-17	Smithkline Beecham Plc	Compounds
FR2701026B1 (fr) *	1993-02-02	1995-03-31	Adir	Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
KR960701865A (ko)	1993-04-22	1996-03-28	데이비드 존. 우드	편두통에 사용하는 5-HT1 유사 효능제인 인돌 유도체(Indole Derivatives as 5-HT, -Like Agonists for Use in Migraine)
GB9317096D0 (en)	1993-08-17	1993-09-29	Pfizer Ltd	Indoles
KR100191973B1 (ko)	1993-08-31	1999-06-15	디. 제이. 우드, 스피겔 알렌 제이	5-아릴인돌 유도체
GB9417310D0 (en)	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
GB9420503D0 (en)	1994-10-11	1994-11-23	Pfizer Ltd	Therapeutic agents
GB9424471D0 (en)	1994-12-03	1995-01-18	Pfizer Ltd	Treatment of emesis

1994
- 1994-10-12 GB GB9420529A patent/GB9420529D0/en active Pending
1995
- 1995-10-05 CZ CZ971118A patent/CZ285633B6/cs not_active IP Right Cessation
- 1995-10-05 MX MX9702732A patent/MX9702732A/es unknown
- 1995-10-05 EP EP95934662A patent/EP0785781B1/en not_active Expired - Lifetime
- 1995-10-05 JP JP08512912A patent/JP3096306B2/ja not_active Expired - Fee Related
- 1995-10-05 ES ES95934662T patent/ES2167465T3/es not_active Expired - Lifetime
- 1995-10-05 DK DK95934662T patent/DK0785781T3/da active
- 1995-10-05 FI FI971527A patent/FI971527A7/fi unknown
- 1995-10-05 AT AT95934662T patent/ATE210980T1/de not_active IP Right Cessation
- 1995-10-05 DE DE69524780T patent/DE69524780T2/de not_active Expired - Fee Related
- 1995-10-05 PL PL95319868A patent/PL319868A1/xx unknown
- 1995-10-05 HU HU9701854A patent/HUT77317A/hu unknown
- 1995-10-05 AU AU36997/95A patent/AU3699795A/en not_active Abandoned
- 1995-10-05 PT PT95934662T patent/PT785781E/pt unknown
- 1995-10-05 CN CN95195603A patent/CN1160347A/zh active Pending
- 1995-10-05 WO PCT/EP1995/003965 patent/WO1996011685A2/en not_active Ceased
- 1995-10-05 CA CA002202484A patent/CA2202484C/en not_active Expired - Fee Related
- 1995-10-06 IL IL11553095A patent/IL115530A/en not_active IP Right Cessation
- 1995-10-11 ZA ZA958557A patent/ZA958557B/xx unknown
- 1995-10-11 PE PE1995281557A patent/PE47296A1/es not_active Application Discontinuation
- 1995-10-11 BR BR9504375A patent/BR9504375A/pt not_active IP Right Cessation
- 1995-10-12 CO CO95047586A patent/CO4480025A1/es unknown
1997
- 1997-04-08 NO NO971606A patent/NO971606L/no not_active Application Discontinuation
- 1997-04-11 KR KR1019970702363A patent/KR970705992A/ko not_active Ceased
1999
- 1999-08-24 JP JP11237456A patent/JP2000080036A/ja active Pending
2000
- 2000-01-27 US US09/494,222 patent/US6455567B1/en not_active Expired - Fee Related
2002
- 2002-08-12 US US10/217,709 patent/US20030055098A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR9504375A (pt)	1997-04-08
JPH09511755A (ja)	1997-11-25
AU3699795A (en)	1996-05-06
CA2202484C (en)	2001-12-18
US6455567B1 (en)	2002-09-24
FI971527L (fi)	1997-04-11
PE47296A1 (es)	1996-11-12
PT785781E (pt)	2002-04-29
EP0785781A2 (en)	1997-07-30
DE69524780D1 (de)	2002-01-31
IL115530A0 (en)	1996-05-14
IL115530A (en)	2001-03-19
PL319868A1 (en)	1997-09-01
GB9420529D0 (en)	1994-11-30
ES2167465T3 (es)	2002-05-16
CN1160347A (zh)	1997-09-24
EP0785781B1 (en)	2001-12-19
KR970705992A (ko)	1997-11-03
JP3096306B2 (ja)	2000-10-10
FI971527A0 (fi)	1997-04-11
CZ111897A3 (cs)	1998-06-17
CA2202484A1 (en)	1996-04-25
DE69524780T2 (de)	2002-06-13
US20030055098A1 (en)	2003-03-20
WO1996011685A3 (en)	1996-08-15
WO1996011685A2 (en)	1996-04-25
ZA958557B (en)	1997-04-11
JP2000080036A (ja)	2000-03-21
FI971527A7 (fi)	1997-04-11
NO971606D0 (no)	1997-04-08
CO4480025A1 (es)	1997-07-09
HUT77317A (hu)	1998-03-30
CZ285633B6 (cs)	1999-10-13
NO971606L (no)	1997-04-08
MX9702732A (es)	1997-06-28
ATE210980T1 (de)	2002-01-15

Publication	Publication Date	Title
DK0785781T3 (da)	2002-03-18	Anvendelse af indolderivater til behandling af dermatologiske lidelser, perifer neuropatisk arthritis, allergisk eller kronisk obstruktiv lungesygdom, glaukom og okulær inflammation
FI943948A0 (fi)	1994-08-26	Heterosykliset hiilihappojohdannaiset
IL160028A (en)	2012-01-31	Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
DK0513702T3 (da)	1996-12-30	Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
EA200400881A1 (ru)	2005-02-24	Азаарилпиперазины
DE60219954D1 (de)	2007-06-14	Neue Indol-2-on Derivate
AU2002359162A1 (en)	2003-07-15	Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
DE69713067D1 (de)	2002-07-11	Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung
DE69525633D1 (de)	2002-04-04	Chinoxalinderivate und ihre therapeutische verwendbarkeit
KR910015300A (ko)	1991-09-30	부스피론 : 수면 무호흡증의 치료용도
PT1658062E (pt)	2010-03-31	Derivados de alfa-amino amida úteis como agentes antiinflamatórios
PT1082116E (pt)	2003-08-29	Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
ECSP951549A (es)	1997-05-16	Nuevo procedimiento de tratamiento
ATE295845T1 (de)	2005-06-15	Prucaloprid-n-oxid
NO913543L (no)	1992-03-11	Fremgangsmaate for fremstilling av 3-(1h-indazol-3-yl)-4-pyridinaminer og mellomprodukter, og anvendelse som medikamenter.
NO20020475D0 (no)	2002-01-29	2-aminotetralinderivater for terapi av glaukom
DK0985414T3 (da)	2003-12-29	Lægemiddel til behandling af glaukome og iskæmisk retinopati
RU97108290A (ru)	1999-05-20	Использование производных индола для лечения различных заболеваний, новый способ лечения
NO20042881L (no)	2004-07-07	Substituerte cykloheksan-derivater
EA200601270A1 (ru)	2006-12-29	Новые индено[2,1-a]индены и изоиндоло[2,1-a]индолы